Total Payments
$417,485
2024 Payments
$25,200
Companies
34
Transactions
961
Medicare Patients
7,985
Medicare Billing
$619,109
Payment Breakdown by Category
Consulting$175,947 (42.1%)
Other$163,181 (39.1%)
Travel$49,774 (11.9%)
Food & Beverage$20,519 (4.9%)
Research$7,733 (1.9%)
Education$331.68 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $175,947 | 62 | 42.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $163,181 | 79 | 39.1% |
| Travel and Lodging | $49,774 | 168 | 11.9% |
| Food and Beverage | $20,519 | 629 | 4.9% |
| Unspecified | $7,733 | 6 | 1.9% |
| Education | $331.68 | 17 | 0.1% |
Payments by Type
General
$409,753
955 transactions
Research
$7,733
6 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $267,252 | 376 | $0 (2022) |
| ABBVIE INC. | $97,546 | 261 | $0 (2024) |
| Galderma Laboratories, L.P. | $21,644 | 72 | $0 (2024) |
| UCB, Inc. | $14,808 | 22 | $0 (2024) |
| MERZ NORTH AMERICA, INC. | $5,215 | 21 | $0 (2024) |
| Eli Lilly and Company | $5,135 | 2 | $0 (2020) |
| Merz Pharmaceuticals GmbH | $1,449 | 19 | $0 (2017) |
| UCB GmBH | $1,167 | 8 | $0 (2018) |
| Janssen Biotech, Inc. | $714.77 | 45 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $318.80 | 19 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $25,200 | 109 | ABBVIE INC. ($23,063) |
| 2023 | $72,746 | 140 | ABBVIE INC. ($72,011) |
| 2022 | $65,333 | 134 | Allergan, Inc. ($62,831) |
| 2021 | $43,081 | 90 | Allergan, Inc. ($42,561) |
| 2020 | $10,942 | 35 | Allergan, Inc. ($8,422) |
| 2019 | $71,530 | 159 | Allergan Inc. ($54,736) |
| 2018 | $59,852 | 126 | Allergan Inc. ($42,472) |
| 2017 | $68,802 | 168 | Allergan Inc. ($56,231) |
All Payment Transactions
961 individual payment records from CMS Open Payments — Page 1 of 39
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | ABBVIE INC. | BOTOX (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $690.00 | General |
| Category: FACIAL AESTHETICS | ||||||
| 12/20/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $1,200.00 | General |
| 12/19/2024 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $11.55 | General |
| Category: Immunology | ||||||
| 12/18/2024 | ABBVIE INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $204.25 | General |
| 12/17/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $17.85 | General |
| Category: Immunology | ||||||
| 12/12/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $24.58 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/11/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $10.04 | General |
| Category: IMMUNOLOGY | ||||||
| 12/05/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $13.13 | General |
| Category: Immunology | ||||||
| 11/21/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $11.85 | General |
| Category: Immunology | ||||||
| 11/19/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $17.20 | General |
| Category: IMMUNOLOGY | ||||||
| 11/14/2024 | ABBVIE INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $348.50 | General |
| 11/14/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $22.11 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/06/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $11.42 | General |
| Category: IMMUNOLOGY | ||||||
| 10/31/2024 | Lilly USA, LLC | OLUMIANT (Drug) | Food and Beverage | In-kind items and services | $15.83 | General |
| Category: Immunology | ||||||
| 10/30/2024 | MERZ NORTH AMERICA, INC. | Xeomin | Food and Beverage | In-kind items and services | $185.04 | General |
| 10/30/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $92.04 | General |
| Category: FACIAL AESTHETICS | ||||||
| 10/24/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $105.01 | General |
| Category: FACIAL AESTHETICS | ||||||
| 10/15/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $9.75 | General |
| Category: IMMUNOLOGY | ||||||
| 10/10/2024 | ABBVIE INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $85.75 | General |
| 10/10/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $9.59 | General |
| Category: Immunology | ||||||
| 10/08/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $15.12 | General |
| Category: Immunology | ||||||
| 10/08/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $12.39 | General |
| Category: FACIAL AESTHETICS | ||||||
| 10/03/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $11.85 | General |
| Category: Immunology | ||||||
| 10/02/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $145.32 | General |
| Category: FACIAL AESTHETICS | ||||||
| 09/27/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $1,200.00 | General |
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A MULTICENTER RANDOMIZED DOUBLE BLIND PLACEBO CONTROLLED STUDY COMPARING THE EFFICACY AND SAFETY OF LY2439821 TO ETANERCEPT AND PLACEBO IN PATIENTS WITH MODERATE TO SEVERE PLAQUE PSORIASIS | Eli Lilly and Company | $4,910 | 1 |
| BOTOX (onabotulinumtoxinA) for the Reduction of Masseter Muscle Prominence: A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study | ABBVIE INC. | $1,498 | 3 |
| 43BBJ1911 | Galderma Laboratories, L.P. | $1,100 | 1 |
| A LONG-TERM STUDY TO ASSESS THE SAFETY AND EFFICACY OF LEBRIKIZUMAB IN PATIENTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS | Eli Lilly and Company | $224.42 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 2,042 | 27,620 | $529,506 | $169,378 |
| 2022 | 17 | 2,018 | 23,933 | $390,164 | $158,136 |
| 2021 | 18 | 1,908 | 22,968 | $344,825 | $140,726 |
| 2020 | 16 | 2,017 | 27,236 | $394,411 | $150,869 |
Total Patients
7,985
Total Services
101,757
Medicare Billing
$619,109
Procedure Codes
67
All Medicare Procedures & Services
67 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 425 | 627 | $114,795 | $39,366 | 34.3% |
| J7345 | Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg | Office | 2023 | 93 | 24,600 | $90,000 | $30,690 | 34.1% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 330 | 422 | $69,630 | $24,994 | 35.9% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 202 | 234 | $43,758 | $17,159 | 39.2% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 248 | 347 | $47,886 | $11,113 | 23.2% |
| 96567 | Application of light to destroy precancer skin growth | Office | 2023 | 93 | 123 | $36,900 | $10,760 | 29.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 102 | 110 | $25,860 | $9,927 | 38.4% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 105 | 173 | $17,139 | $6,112 | 35.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 154 | 171 | $20,775 | $5,343 | 25.7% |
| 17261 | Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | Office | 2023 | 36 | 41 | $10,045 | $4,373 | 43.5% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 24 | 26 | $7,774 | $3,500 | 45.0% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 162 | 627 | $30,990 | $2,854 | 9.2% |
| 40490 | Biopsy of lip | Office | 2023 | 13 | 13 | $2,938 | $1,228 | 41.8% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 21 | 46 | $6,662 | $1,226 | 18.4% |
| 69100 | Biopsy of ear | Office | 2023 | 13 | 14 | $2,534 | $703.95 | 27.8% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 21 | 46 | $1,820 | $31.59 | 1.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 421 | 596 | $80,460 | $38,690 | 48.1% |
| J7345 | Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg | Office | 2022 | 70 | 21,200 | $42,400 | $25,827 | 60.9% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 310 | 404 | $66,660 | $24,403 | 36.6% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 167 | 192 | $35,904 | $13,938 | 38.8% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 259 | 336 | $46,368 | $11,640 | 25.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 277 | 308 | $23,100 | $9,846 | 42.6% |
| 96567 | Application of light to destroy precancer skin growth | Office | 2022 | 70 | 106 | $31,800 | $9,499 | 29.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 69 | 77 | $14,322 | $6,894 | 48.1% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2022 | 93 | 142 | $10,934 | $5,063 | 46.3% |
About Dr. Rosalyn George, M.D
Dr. Rosalyn George, M.D is a Dermatology healthcare provider based in Wilmington, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/03/2007. The National Provider Identifier (NPI) number assigned to this provider is 1639391931.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Rosalyn George, M.D has received a total of $417,485 in payments from pharmaceutical and medical device companies, with $25,200 received in 2024. These payments were reported across 961 transactions from 34 companies. The most common payment nature is "Consulting Fee" ($175,947).
As a Medicare-enrolled provider, George has provided services to 7,985 Medicare beneficiaries, totaling 101,757 services with total Medicare billing of $619,109. Data is available for 4 years (2020–2023), covering 67 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Other Specialties Dermatology
- Location Wilmington, NC
- Active Since 05/03/2007
- Last Updated 12/13/2010
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1639391931
Products in Payments
- BOTOX (Biological) $109,478
- KYBELLA (Biological) $37,559
- BOTOX COSMETIC (Biological) $24,370
- Cimzia (Drug) $14,786
- TALTZ (Drug) $5,129
- Xeomin (Biological) $2,041
- RINVOQ (Biological) $690.65
- TREMFYA (Drug) $612.45
- SKYRIZI (Biological) $531.26
- Humira (Biological) $464.48
- Klisyri (Drug) $216.11
- COSENTYX (Biological) $210.53
- HUMIRA (Biological) $202.96
- DUPIXENT (Biological) $191.98
- DUPIXENT (Drug) $179.20
- EUCRISA (Drug) $172.47
- DUPIXENT DUPILUMAB INJECTION (Biological) $130.47
- Sotyktu (Drug) $110.46
- COSENTYX (Drug) $108.27
- Winlevi (Drug) $69.64
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Wilmington
Laura Tanner, M.d, M.D
Dermatology — Payments: $85,157
Dermatology $85,157
Mr. James Appel, M.d, M.D
Dermatology — Payments: $35,878
Dermatology $35,878
Dr. Aron Gewirtzman, M.d, M.D
Dermatology — Payments: $24,635
Dermatology $24,635
Dr. Michael Rosenthal, D.o, D.O
Dermatology — Payments: $21,448
Dermatology $21,448
Dr. Jonathan Crane, D.o, D.O
Dermatology — Payments: $12,737
Dermatology $12,737
Dr. Chloe Payne, M.d, M.D
Dermatology — Payments: $5,335
Dermatology $5,335